Effect of Hyperthermia on Astatine-211 Labelled Antibody in Tumor Spheroids
Author Information
Author(s): ML Hauck, RH Larsen, PC Welsh, MR Zalutsky
Primary Institution: Duke University Medical Center
Hypothesis
Does hyperthermia increase the cytotoxicity of astatine-211 labelled monoclonal antibodies in tumor spheroids?
Conclusion
Hyperthermia at 42°C for 1 hour did not enhance the cytotoxicity of astatine-211 labelled antibodies in glioma spheroids.
Supporting Evidence
- Hyperthermia did not increase the cytotoxicity of the monoclonal antibody at any tested concentration.
- Significant regrowth delay was observed at certain activity concentrations, but hyperthermia had no effect.
- Autoradiographs showed no significant improvement in antibody distribution within the spheroids due to hyperthermia.
Takeaway
The study tested if heating tumors could help a special treatment work better, but it found that heating didn't make the treatment more effective.
Methodology
The study used D-247 MG human glioma spheroids and tested the effect of hyperthermia on the uptake and cytotoxicity of astatine-211 labelled monoclonal antibodies.
Limitations
The study only tested a short duration of hyperthermia and did not explore longer treatment times that might be more effective.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website